PANAGORA ASSET MANAGEMENT INC - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 95 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 59.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$2,532,000
-30.0%
226,098
-31.2%
0.01%
-33.3%
Q2 2017$3,617,000
+42.1%
328,788
+26.5%
0.02%
+36.4%
Q1 2017$2,546,000
+24.5%
259,822
+37.2%
0.01%
+22.2%
Q4 2016$2,045,000
-30.2%
189,320
-33.8%
0.01%
-35.7%
Q3 2016$2,930,000
+49.0%
285,833
+89.9%
0.01%
+40.0%
Q2 2016$1,966,000
+9.5%
150,511
-7.7%
0.01%
+11.1%
Q1 2016$1,795,000
+23.7%
163,149
+3.5%
0.01%
+28.6%
Q4 2015$1,451,000
+70.9%
157,681
+28.8%
0.01%
+75.0%
Q3 2015$849,000
-8.1%
122,390
+30.1%
0.00%
-20.0%
Q2 2015$924,000
+616.3%
94,076
+544.2%
0.01%
+400.0%
Q1 2015$129,000
+0.8%
14,6030.0%0.00%0.0%
Q4 2014$128,000
-36.3%
14,603
-50.0%
0.00%0.0%
Q3 2014$201,000
+30.5%
29,2050.0%0.00%0.0%
Q2 2014$154,000
+15.8%
29,2050.0%0.00%0.0%
Q1 2014$133,000
-9.5%
29,2050.0%0.00%0.0%
Q4 2013$147,00029,2050.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Athos Capital Ltd 410,389$4,596,0003.46%
GLG Partners LP 2,586,437$28,968,0001.54%
Nine Chapters Capital Management LLC 32,300$362,0000.80%
FNY Partners Fund LP 335,900$3,762,0000.64%
MENTA CAPITAL LLC 373,523$4,183,0000.61%
Yakira Capital Management, Inc. 85,500$958,0000.32%
Sapphire Star Partners LP 18,724$209,0000.27%
GAM Holding AG 541,025$6,059,0000.26%
Bowling Portfolio Management LLC 127,873$1,432,0000.22%
Kassirer Asset Management Corp 15,000$168,0000.16%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders